Skip to content

Author

Rossella Del Frate

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Kdm2a histone demethylase ablation restores anti-tumor immunogenicity in liver cancer.

KDM2A acts as a key epigenetic regulator of mitochondrial function, genomic stability, and the tumor immune microenvironment in liver cancer, and may enhance tumor immunogenicity and improve responses to immunotherapy, representing a promising therapeutic strategy.

L. Gragnani, M. Lulli, Patrizio Caini et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.